Targeted apoptosis activation with GrB/scFvMEL modulates melanoma growth, metastatic spread, chemosensitivity, and radiosensitivity.
about
Multi-modality therapeutics with potent anti-tumor effects: photochemical internalization enhances delivery of the fusion toxin scFvMEL/rGelNeoplasia: Where We Have Been and Where We Are GoingNanovehicles as a novel target strategy for hyperthermic intraperitoneal chemotherapy: a multidisciplinary study of peritoneal carcinomatosisImmunotherapeutic targeting of membrane Hsp70-expressing tumors using recombinant human granzyme BNeoplasia: the second decade.EGFR-targeted granzyme B expressed in NK cells enhances natural cytotoxicity and mediates specific killing of tumor cells.Delivery and therapeutic potential of human granzyme B.Attenuation of mouse melanoma by A/C magnetic field after delivery of bi-magnetic nanoparticles by neural progenitor cells.Development of human serine protease-based therapeutics targeting Fn14 and identification of Fn14 as a new target overexpressed in TNBC.Targeting granzyme B to tumor cells using a yoked human chorionic gonadotropinConstruction and characterization of novel, completely human serine protease therapeutics targeting Her2/neuThe functionalized human serine protease granzyme B/VEGF₁₂₁ targets tumor vasculature and ablates tumor growth.Antibody-enzyme fusion proteins for cancer therapy.A novel approach for targeted elimination of CSPG4-positive triple-negative breast cancer cells using a MAP tau-based fusion protein.Immunotoxins in cancer therapy: Review and update.Characterization and mechanistic studies of a novel melanoma-targeting construct containing IκBa for specific inhibition of nuclear factor-κB activity.Neoplasia: An Anniversary of Progress.Addressing the Immunogenicity of the Cargo and of the Targeting Antibodies with a Focus on Demmunized Bacterial Toxins and on Antibody-Targeted Human Effector Proteins.
P2860
Q27343143-1A2DC250-194E-4DCC-B646-96230A94D5E4Q28395095-4EA525C8-0A06-45A4-AD45-A8E06F708045Q28395895-E9B5379E-F980-4A0F-8F1D-68D3C74A43C5Q28729023-5613BDF4-6E08-4C56-9F98-C6B5638EEC95Q30484000-EAB58DF3-6458-4FEA-9CA8-A7536E5C9464Q31115054-30471674-600B-469F-9278-B394F7623178Q34120062-47D9FDC9-1F72-4BA3-9798-20B3D7A3A254Q34444417-A59B9E88-B4DA-414B-9854-595391F1415DQ34773994-0F3EBFC5-BE44-48FD-A613-5E67F5D5728BQ35233582-3A5E4AE1-C31E-47BE-BD05-36FAB7C2B742Q35541200-0F1AF2C4-57AD-4AAB-8372-30669279C42AQ37577621-5656A0DE-37B1-4A76-BE9E-EA0B976A5A8EQ37842324-5FB334ED-3B7D-4BF2-9811-2F1F236B0434Q38781425-0B9E4F66-FB90-4A09-8D01-4F14E9AFF507Q39172843-DF12A57E-758E-4624-97EE-072A28CF844AQ41990475-B6E8B99F-2F1B-42A8-B044-97CBE9F077ECQ46932476-6A320BE5-A3E2-4E34-9166-0D92A882036DQ50962872-A49D57A0-B08F-4FC7-AD7C-1C446DA50687
P2860
Targeted apoptosis activation with GrB/scFvMEL modulates melanoma growth, metastatic spread, chemosensitivity, and radiosensitivity.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Targeted apoptosis activation ...... itivity, and radiosensitivity.
@ast
Targeted apoptosis activation ...... itivity, and radiosensitivity.
@en
type
label
Targeted apoptosis activation ...... itivity, and radiosensitivity.
@ast
Targeted apoptosis activation ...... itivity, and radiosensitivity.
@en
prefLabel
Targeted apoptosis activation ...... itivity, and radiosensitivity.
@ast
Targeted apoptosis activation ...... itivity, and radiosensitivity.
@en
P2093
P2860
P356
P1433
P1476
Targeted apoptosis activation ...... itivity, and radiosensitivity.
@en
P2093
Anupama Munshi
Lawrence H Cheung
Michael G Rosenblum
Raymond E Meyn
Weihe Zhang
Yuying Liu
P2860
P304
P356
10.1593/NEO.05556
P577
2006-02-01T00:00:00Z